Evogene (EVGN) Tops Q1 EPS by 2c

Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.15), $0.02 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $640 thousand versus the consensus estimate of $590 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture downgraded by TD Cowen on AI concerns
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings